Dr. Shapiro specializes in treating patients with scleroderma, a chronic autoimmune disease that causes a hardening and tightening of the skin and connective tissues. It can also affect the lungs, kidneys, heart and other internal organs. In the U.S., approximately 75,000 to 100,000 people have scleroderma; most are women between the ages of 30 and 50. There is presently no cure, but proper treatment can reduce symptoms and damage from the disease.

An active researcher, Dr. Shapiro also serves as the chief medical officer for the Ann Steffens Scleroderma Research Foundation. He has been honored as Doctor of the Year by the Scleroderma Foundation and inducted into the CDPHP Physicians Academy, which recognizes physicians who serve as role models to their medical colleagues and who act as ambassadors in fostering the delivery of high-value health care.

Research Topics